Managed Healthcare Executive March 12, 2020
Jennifer Gershman, PharmD, CPh

Cancer is not quite the ferocious killer that it used to be. Millions of Americans are living with cancer, not just dying from it. Reasons for the diminishing death rate include lower smoking rates, earlier detection of some cancers, and advances in treatment.

But the treatment advances are coming at a high price. Treatment costs can easily exceed $100,000 a year. In response, CMS and commercial insurers are establishing alternative payment models, which, in theory, are supposed to slow down the stampeding costs while protecting, and perhaps even improving, the quality of cancer care.

The Oncology Care Model (OCM) developed by CMS’s Center for Medicare and Medicaid Innovation (CMMI) is certainly the highest profile of these alternative payment model....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Health System / Hospital, Insurance, Medicare, Payment Models, Physician, Provider, Value Based
How extending virtual options can drive value-based care
Health system C-suites eye value-based care roles
Incentivizing Provider Engagement for Improved Value-Based Outcomes
201: Value series: What does health system VBC adoption actually look like?
Creating a Roadmap to Value-Based Care in Autism

Share This Article